{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:43:55Z","timestamp":1793947435444,"version":"4.8.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T00:00:00Z","timestamp":1682726400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA222490"],"award-info":[{"award-number":["R01CA222490"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R50CA243787"],"award-info":[{"award-number":["R50CA243787"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA108459-15"],"award-info":[{"award-number":["T32 CA108459-15"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California, Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ymthe.2023.04.019","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T02:38:33Z","timestamp":1683167913000},"page":"1829-1845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism"],"prefix":"10.1016","volume":"31","author":[{"given":"Ying","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Setayesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzam","family":"Vaziri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel T.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2243-7759","authenticated-orcid":false,"given":"Yu-Jui","family":"Yvonne Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2023.04.019_bib1","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41575-019-0240-9","article-title":"Harnessing big 'omics' data and AI for drug discovery in hepatocellular carcinoma","volume":"17","author":"Chen","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.livres.2020.11.006","article-title":"Hepatocellular carcinoma diagnosis and treatment: an overview","volume":"4","author":"Colquhoun","year":"2020","journal-title":"Liver Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2019.09.010","article-title":"Molecular therapies for HCC: looking outside the box","volume":"72","author":"Faivre","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ymthe.2023.04.019_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154515","article-title":"beta-Catenin signaling in hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.04.019_bib7","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/hepr.13191","article-title":"Immune checkpoint blockade for the treatment of human hepatocellular carcinoma","volume":"48","author":"Nishida","year":"2018","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.livres.2020.10.001","article-title":"Hepatocellular carcinoma immunotherapy: the impact of epigenetic drugs and the gut microbiome","volume":"4","author":"Vaziri","year":"2020","journal-title":"Liver Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3892\/ijo.2016.3811","article-title":"Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review)","volume":"50","author":"Wang","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.29832","article-title":"MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma","volume":"68","author":"Mansini","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2023.04.019_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12943-017-0751-3","article-title":"The Jun\/miR-22\/HuR regulatory axis contributes to tumourigenesis in colorectal cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2023.04.019_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/7843565","article-title":"miR-22 suppresses EMT by mediating metabolic reprogramming in colorectal cancer through targeting MYC-associated factor X","volume":"2022","author":"Xia","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.ymthe.2023.04.019_bib13","first-page":"1221","article-title":"MiR-22-3p suppresses cell growth via MET\/STAT3 signaling in lung cancer","volume":"13","author":"Yang","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1080\/15384047.2020.1838031","article-title":"The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy","volume":"21","author":"Konishi","year":"2020","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ymthe.2023.04.019_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.4149\/neo_2020_190418N350","article-title":"RGMB-AS1\/miR-22-3p\/NFIB axis contributes to the progression of gastric cancer","volume":"67","author":"Zhang","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.ymthe.2023.04.019_bib16","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s11010-021-04065-w","article-title":"Twist activates miR-22 to suppress estrogen receptor alpha in breast cancer","volume":"476","author":"Vesuna","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ymthe.2023.04.019_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002518","article-title":"CD63(+) cancer-associated fibroblasts confer tamoxifen resistance to breast cancer cells through exosomal miR-22","volume":"7","author":"Gao","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2023.04.019_bib18","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1158\/1078-0432.CCR-10-1734","article-title":"miR-22 promotes HBV-related hepatocellular carcinoma development in males","volume":"17","author":"Jiang","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib19","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1074\/jbc.M114.620369","article-title":"MiR-22-silenced cyclin A expression in colon and liver cancer cells is regulated by bile acid receptor","volume":"290","author":"Yang","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2023.04.019_bib20","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1096\/fj.201801390R","article-title":"RARbeta acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells","volume":"33","author":"Hu","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2023.04.019_bib21","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1093\/hmg\/dds031","article-title":"MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells","volume":"21","author":"Alvarez-D\u00edaz","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymthe.2023.04.019_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/path.4983","article-title":"Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation","volume":"243","author":"Sheng","year":"2017","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib23","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jhep.2015.08.001","article-title":"Implications of microbiota and bile acid in liver injury and regeneration","volume":"63","author":"Liu","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41575-019-0108-z","article-title":"Precision dietary supplementation based on personal gut microbiota","volume":"16","author":"Wan","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105930","article-title":"Genome-wide binding and transcriptome analysis of human farnesoid X receptor in primary human hepatocytes","volume":"9","author":"Zhan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.04.019_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1124\/jpet.107.132258","article-title":"Hepatocyte retinoid X receptor alpha-dependent regulation of lipid homeostasis and inflammatory cytokine expression contributes to alcohol-induced liver injury","volume":"324","author":"Gyamfi","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2023.04.019_bib27","first-page":"17","article-title":"The inhibition role of miR-22 in hepatocellular carcinoma cell migration and invasion via targeting CD147","volume":"17","author":"Luo","year":"2017","journal-title":"Cancer Cel Int."},{"key":"10.1016\/j.ymthe.2023.04.019_bib28","article-title":"miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction","volume":"2","author":"Hu","year":"2020","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ymthe.2023.04.019_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.livres.2020.06.001","article-title":"MiR-22 as a metabolic silencer and liver tumor suppressor","volume":"4","author":"Wang","year":"2020","journal-title":"Liver Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib30","article-title":"Histone methyltransferase SETDB1 promotes immune evasion in colorectal cancer via FOSB-mediated downregulation of MicroRNA-22 through BATF3\/PD-L1 pathway","volume":"2022","author":"Tian","year":"2022","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib31","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7150\/ijms.8647","article-title":"Expression, regulation and function of microRNAs in multiple sclerosis","volume":"11","author":"Ma","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ymthe.2023.04.019_bib32","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/ni.3292","article-title":"The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote T(H)17 cell-dependent emphysema","volume":"16","author":"Lu","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib33","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-10-2705","article-title":"Coactivation of AKT and beta-catenin in mice rapidly induces formation of lipogenic liver tumors","volume":"71","author":"Stauffer","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.21037\/atm-20-2229","article-title":"Impact of splenomegaly and splenectomy on prognosis in hepatocellular carcinoma with portal vein tumor thrombus treated with hepatectomy","volume":"9","author":"Chai","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ymthe.2023.04.019_bib35","article-title":"Hepatocellular carcinoma and multiple myeloma with elevated globulin: a case report and literature review","volume":"48","author":"Xu","year":"2020","journal-title":"J.\u00a0Int. Med. Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib36","article-title":"Paraneoplastic hypoglycemia in hepatocarcinoma: case report and literature review","volume":"12","author":"Regino","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.ymthe.2023.04.019_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12876-018-0893-9","article-title":"Macrocytic anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study","volume":"18","author":"Yang","year":"2018","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib38","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"Beta-catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2023.04.019_bib39","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.jhep.2014.08.025","article-title":"Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions","volume":"61","author":"Wilson","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib40","doi-asserted-by":"crossref","first-page":"46691","DOI":"10.18632\/oncotarget.17358","article-title":"Hypoxia inducible factors in hepatocellular carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2023.04.019_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020291","article-title":"MicroRNA-22 regulates hypoxia signaling in colon cancer cells","volume":"6","author":"Yamakuchi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymthe.2023.04.019_bib42","doi-asserted-by":"crossref","first-page":"e71715","DOI":"10.3390\/cells10071715","article-title":"Hypoxia, metabolic reprogramming, and drug resistance in liver cancer","volume":"10","author":"Bao","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.ymthe.2023.04.019_bib43","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.4049\/jimmunol.166.12.7543","article-title":"Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia","volume":"166","author":"Narravula","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1194\/jlr.M021030","article-title":"Choline phosphorylation and regulation of transcription of choline kinase alpha in hypoxia","volume":"53","author":"Bansal","year":"2012","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib45","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1038\/s41388-021-01846-x","article-title":"Targeting HIF-1 alpha transcriptional activity drives cytotoxic immune effector cells into melanoma and improves combination immunotherapy","volume":"40","author":"Lequeux","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2023.04.019_bib46","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.1158\/0008-5472.CAN-16-3167","article-title":"PD-1 status in CD8(+) T\u00a0cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer","volume":"77","author":"Kansy","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib47","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.181.4.2277","article-title":"Retinoic acid increases Foxp3+ regulatory T\u00a0cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression","volume":"181","author":"Xiao","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib48","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1172\/JCI44262","article-title":"Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice","volume":"121","author":"Hammerschmidt","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.ymthe.2023.04.019_bib49","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.immuni.2012.07.004","article-title":"The RIG-I-like receptor LGP2 controls CD8(+) T\u00a0cell survival and fitness","volume":"37","author":"Suthar","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.04.019_bib50","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13045-020-00897-z","article-title":"Th17 cells inhibit CD8(+) T\u00a0cell migration by systematically downregulating CXCR3 expression via IL-17A\/STAT3 in advanced-stage colorectal cancer patients","volume":"13","author":"Wang","year":"2020","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib51","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2023.04.019_bib52","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni.1995","article-title":"Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5","volume":"12","author":"Yang","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib53","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.jid.2021.10.027","article-title":"Bile acids improve psoriasiform dermatitis through inhibition of IL-17a expression and CCL20-CCR6-mediated trafficking of T\u00a0cells","volume":"142","author":"Shi","year":"2022","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib54","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41571-019-0175-7","article-title":"Regulatory T\u00a0cells in cancer immunosuppression - implications for anticancer therapy","volume":"16","author":"Togashi","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib55","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.addr.2010.07.003","article-title":"Retinoid pathway and cancer therapeutics","volume":"62","author":"Bushue","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ymthe.2023.04.019_bib56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.immuni.2015.02.003","article-title":"Retinoic acid is essential for Th1 cell lineage stability and prevents transition to a Th17 cell program","volume":"42","author":"Brown","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2023.04.019_bib57","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1159\/000438631","article-title":"Hepatocellular carcinoma cells induce regulatory T\u00a0cells and lead to poor prognosis via production of transforming growth factor-beta1","volume":"38","author":"Wang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ymthe.2023.04.019_bib58","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/hep.20644","article-title":"Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells","volume":"41","author":"Unitt","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2023.04.019_bib59","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","article-title":"Hydrodynamic transfection for generation of novel mouse models for liver cancer research","volume":"184","author":"Chen","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib60","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/978-1-4939-7568-6_23","article-title":"Isolation and characterization of mouse intrahepatic lymphocytes by flow cytometry","volume":"1725","author":"Wiede","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1875036201307010001","article-title":"Comparison of sequencing utility programs","volume":"7","author":"Aronesty","year":"2013","journal-title":"Open Bioinforma. J."},{"key":"10.1016\/j.ymthe.2023.04.019_bib62","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.4197","article-title":"Salmon provides fast and bias-aware quantification of transcript expression","volume":"14","author":"Patro","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymthe.2023.04.019_bib63","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","article-title":"Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences","volume":"4","author":"Soneson","year":"2015","journal-title":"F1000Res."},{"key":"10.1016\/j.ymthe.2023.04.019_bib64","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib65","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2023.04.019_bib66","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s12859-018-2486-6","article-title":"iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data","volume":"19","author":"Ge","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ymthe.2023.04.019_bib67","article-title":"An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation","author":"Sergushichev","year":"2016","journal-title":"bioRxiv"},{"key":"10.1016\/j.ymthe.2023.04.019_bib68","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"Goldman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib69","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.bcp.2013.01.023","article-title":"Transcriptome profiling and genome-wide DNA binding define the differential role of fenretinide and all-trans RA in regulating the death and survival of human hepatocellular carcinoma Huh7 cells","volume":"85","author":"Hu","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib70","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib71","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4143\/crt.2014.321","article-title":"The prognostic role of mitotic index in hepatocellular carcinoma patients after curative hepatectomy","volume":"48","author":"Ha","year":"2016","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.ymthe.2023.04.019_bib72","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.ajpath.2014.08.002","article-title":"Accelerated partial hepatectomy-induced liver cell proliferation is associated with liver injury in Nur77 knockout mice","volume":"184","author":"Hu","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2023.04.019_bib73","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2023.04.019_bib74","first-page":"1043","article-title":"Does beta blockade postinjury prevent bone marrow suppression?","volume":"70","author":"Mohr","year":"2011","journal-title":"J.\u00a0Trauma"},{"key":"10.1016\/j.ymthe.2023.04.019_bib75","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1002\/hep.30528","article-title":"An efficient combination immunotherapy for primary liver cancer by harmonized activation of innate and adaptive immunity in mice","volume":"69","author":"Wen","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2023.04.019_bib76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/hum.2005.16.126","article-title":"Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in\u00a0vivo","volume":"16","author":"Chen","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ymthe.2023.04.019_bib77","doi-asserted-by":"crossref","first-page":"951","DOI":"10.4049\/jimmunol.1003986","article-title":"IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass","volume":"187","author":"Adamopoulos","year":"2011","journal-title":"J.\u00a0Immunol."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623002538?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001623002538?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:08:01Z","timestamp":1761502081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001623002538"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1525001623002538"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.04.019","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2023.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s).","name":"copyright","label":"Copyright"}]}}